A landmark clinical trial has essentially cured patients of the debilitating genetic disorder.
Tag: Gene
Gene-Silencing Therapy Safely Lowers LRRK2 Protein in Early Parkinson’s Disease Trial
An experimental therapy targeting the LRRK2 gene safely reduced the relevant protein levels in an early-stage Parkinson’s clinical trial.